Patient Guide: A Study to Compare the Efficacy and Safety of a Combined Regimen of Venetoclax and Obinutuzumab Versus Fludarabine, Cyclophosphamide, and Rituximab (FCR)/ Bendamustine And Rituximab (BR) in FIT Patients With Previously Untreated Chronic Lymphocytic Leukemia (CLL) Without DEL (17P) or TP53 Mutation

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 40 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT04285567
Status: COMPLETED
Condition: Chronic Lymphocytic Leukemia (CLL)
Phase: PHASE3

Find a Study Location Near You

This study is available at 40 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Aurora, Colorado
  • Bethesda, Maryland
  • Knoxville, Tennessee
  • • And 37 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily